Thomas Cerny Kantonsspital St.Gallen thomas.cerny@kssg.ch www ...
Thomas Cerny Kantonsspital St.Gallen thomas.cerny@kssg.ch www ...
Thomas Cerny Kantonsspital St.Gallen thomas.cerny@kssg.ch www ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Weiterbildung LUKS Onkologie, 4/12<br />
Tumortyp Eventuelle Therapieoptionen 1<br />
T. <strong>Cerny</strong>,<br />
Synovialsarkom<br />
Liposarkom<br />
Leiomyosarkome<br />
uterine Leiomyosarkome<br />
Endometriale <strong>St</strong>romasarkome (low‐grade)<br />
Gastrointestinale <strong>St</strong>romatumoren<br />
Dermatofibrosarcoma protuberans<br />
(t:17;12)<br />
Desmoide<br />
Ifosfamid + Adriamycin, Trabectedin<br />
Adriamycin, Ifosfamid, Trabectedin,<br />
Gemcitabin ± Docetaxel, DTIC<br />
Adriamycin, Ifosfamid, Gemcitabin ±<br />
Docetaxel, Trabectedin, DTIC<br />
Adriamycin (±DTIC / ±Ifosfamid),<br />
Gemcitabin + Docetaxel, Ifosfamid,<br />
Trabectedin<br />
Aromataseinhibitoren, Gestagene, GnRH‐<br />
Analoga<br />
Imatinib, Sunitinib<br />
Imatinib<br />
NSAID, Tamoxifen, Interferon, (lipos.)<br />
Adriamycin, Vinca‐Alkaloide., Methotrexat,<br />
Imatinib, Sorafenib